https://www.selleckchem.com/pr....oducts/ide397-gsk-43
The COVID-19 pandemic continues to exert an immense burden on global health services. Moreover, up to 63% of patients experience persistent symptoms, including fatigue, after acute illness. Endocrine systems are vulnerable to the effects of COVID-19 as many glands express the ACE2 receptor, used by the SARS-CoV-2 virion for cellular access. However, the effects of COVID-19 on adrenal and thyroid gland function after acute COVID-19 remain unknown. Our objectives were to evaluate adrenal and thyroid gland function in COVID-19 s
Like
Comment
Share
